Cite
HARVARD Citation
Passik, S. et al. (2014). Aberrant Drug‐Related Behavior Observed During a 12‐Week Open‐Label Extension Period of a Study Involving Patients Taking Chronic Opioid Therapy for Persistent Pain and Fentanyl Buccal Tablet or Traditional Short‐Acting Opioid for Breakthrough Pain. Pain medicine. 15 (8), pp. 1365-1372. [Online].